https://stock.noler.com/us/stock/carisma-therapeutics-inc https://stock.noler.com/us/stock/carisma-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/carisma-therapeutics-inc/accounts-receivable https://stock.noler.com/us/stock/carisma-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/carisma-therapeutics-inc/accrual-at-carrying-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquired-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquired-cash-and-equivalents https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquired-current-assets-marketable-securities https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquired-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquired-current-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-contingent-consideration-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-contingent-consideration-liability-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-contingent-consideration-liability-measurement-input https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-provisional-information-initial-accounting-incomplete-adjustment-consideration-transferred https://stock.noler.com/us/stock/carisma-therapeutics-inc/acquisition-recognized-identifiable-assets-acquired-goodwill-and-liabilities-assumed-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/carisma-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/carisma-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/carisma-therapeutics-inc/aoci https://stock.noler.com/us/stock/carisma-therapeutics-inc/asset-impairment-charges https://stock.noler.com/us/stock/carisma-therapeutics-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/carisma-therapeutics-inc/assets-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/assets-of-disposal-group-including-discontinued-operation-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/carisma-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/carisma-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/carisma-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/carisma-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/carisma-therapeutics-inc/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/carisma-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/carisma-therapeutics-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/carisma-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/carisma-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/carisma-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-each-warrant-or-right https://stock.noler.com/us/stock/carisma-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/carisma-therapeutics-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/carisma-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/carisma-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/carisma-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/carisma-therapeutics-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/carisma-therapeutics-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/carisma-therapeutics-inc/construction-payable-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/contract-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/carisma-therapeutics-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/carisma-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/carisma-therapeutics-inc/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/carisma-therapeutics-inc/current-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/debt-carrying-amount https://stock.noler.com/us/stock/carisma-therapeutics-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/carisma-therapeutics-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/carisma-therapeutics-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/carisma-therapeutics-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-compensation-share-based-arrangements-liability-classified-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-revenue https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-compensation-and-benefits-compensated-absences https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-liabilities-deferred-expense-capitalized-research-and-development-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/carisma-therapeutics-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/carisma-therapeutics-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/carisma-therapeutics-inc/defined-contribution-plan-maximum-annual-contributions-per-employee-percent https://stock.noler.com/us/stock/carisma-therapeutics-inc/deposits-assets-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/carisma-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/carisma-therapeutics-inc/due-from-related-parties-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/due-to-related-parties-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/carisma-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/eps https://stock.noler.com/us/stock/carisma-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/carisma-therapeutics-inc/estimate-of-possible-loss https://stock.noler.com/us/stock/carisma-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/carisma-therapeutics-inc/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/fair-value-net-derivative-asset-liability-unobservable-inputs-reconciliation-change https://stock.noler.com/us/stock/carisma-therapeutics-inc/fair-value-of-assets-acquired https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-impairment-loss https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-interest-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-interest-payment-on-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-due https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-due-after-year-five https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-due-next-twelve-months https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-due-year-five https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-due-year-four https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-due-year-three https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-due-year-two https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-principal-payments https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-right-of-use-asset-accumulated-amortization https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-right-of-use-asset-amortization https://stock.noler.com/us/stock/carisma-therapeutics-inc/finance-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/carisma-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/carisma-therapeutics-inc/foreign-pretax-income https://stock.noler.com/us/stock/carisma-therapeutics-inc/form-d-other https://stock.noler.com/us/stock/carisma-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/carisma-therapeutics-inc/gain-loss-on-sale-of-other-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/carisma-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/carisma-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/goodwill https://stock.noler.com/us/stock/carisma-therapeutics-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/carisma-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/carisma-therapeutics-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/carisma-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/carisma-therapeutics-inc/income-loss-attributable-to-parent https://stock.noler.com/us/stock/carisma-therapeutics-inc/income-tax https://stock.noler.com/us/stock/carisma-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-other-noncurrent-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/increase-decrease-in-restricted-cash-for-operating-activities https://stock.noler.com/us/stock/carisma-therapeutics-inc/incremental-common-shares-attributable-to-call-options-and-warrants https://stock.noler.com/us/stock/carisma-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/carisma-therapeutics-inc/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/carisma-therapeutics-inc/indefinite-lived-license-agreements https://stock.noler.com/us/stock/carisma-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/carisma-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/carisma-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/carisma-therapeutics-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/carisma-therapeutics-inc/insider-transactions-warrants https://stock.noler.com/us/stock/carisma-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/carisma-therapeutics-inc/interest-expense-on-debt https://stock.noler.com/us/stock/carisma-therapeutics-inc/interest-income-expense-nonoperating-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/interest-paid https://stock.noler.com/us/stock/carisma-therapeutics-inc/interest-paid-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/interest-payable-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/carisma-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/carisma-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/carisma-therapeutics-inc/lease-cost https://stock.noler.com/us/stock/carisma-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/carisma-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/carisma-therapeutics-inc/level-3-liability-change https://stock.noler.com/us/stock/carisma-therapeutics-inc/level-3-liability-issues https://stock.noler.com/us/stock/carisma-therapeutics-inc/level-3-liability-transfers-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/liabilities-assumed https://stock.noler.com/us/stock/carisma-therapeutics-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/carisma-therapeutics-inc/liabilities-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/license-and-maintenance-revenue https://stock.noler.com/us/stock/carisma-therapeutics-inc/license-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/carisma-therapeutics-inc/litigation-reserve https://stock.noler.com/us/stock/carisma-therapeutics-inc/long-term-notes-payable https://stock.noler.com/us/stock/carisma-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/marketable-securities-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/marketable-securities-realized-gain-loss-excluding-other-than-temporary-impairments https://stock.noler.com/us/stock/carisma-therapeutics-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/carisma-therapeutics-inc/minority-interest https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-income https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/carisma-therapeutics-inc/net-income-loss-from-discontinued-operations-available-to-common-shareholders-basic https://stock.noler.com/us/stock/carisma-therapeutics-inc/noncash-or-part-noncash-acquisition-debt-assumed https://stock.noler.com/us/stock/carisma-therapeutics-inc/noncash-or-part-noncash-acquisition-noncash-financial-or-equity-instrument-consideration-warrants-issued https://stock.noler.com/us/stock/carisma-therapeutics-inc/notes-payable-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/notes-reduction https://stock.noler.com/us/stock/carisma-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/carisma-therapeutics-inc/number-of-reportable-segments https://stock.noler.com/us/stock/carisma-therapeutics-inc/number-of-reporting-units https://stock.noler.com/us/stock/carisma-therapeutics-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/carisma-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-income https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-leases-rent-expense-minimum-rentals https://stock.noler.com/us/stock/carisma-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-income https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-receivables-gross-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-receivables-net-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/other-sales-revenue-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/carisma-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/carisma-therapeutics-inc/paid-in-kind-interest https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-for-legal-settlements https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-for-proceeds-from-productive-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-for-restructuring https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-of-financing-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/carisma-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/carisma-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/prepaid-expense-current-and-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/prepaid-insurance https://stock.noler.com/us/stock/carisma-therapeutics-inc/pretax-income https://stock.noler.com/us/stock/carisma-therapeutics-inc/pretax-income-domestic https://stock.noler.com/us/stock/carisma-therapeutics-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-collaborators https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-royalties-received https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-sale-of-machinery-and-equipment https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-sale-of-other-property-plant-and-equipment https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-sale-of-property-held-for-sale https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/carisma-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/carisma-therapeutics-inc/professional-fees https://stock.noler.com/us/stock/carisma-therapeutics-inc/profit-loss https://stock.noler.com/us/stock/carisma-therapeutics-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/carisma-therapeutics-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-after-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/carisma-therapeutics-inc/property-plant-and-equipment-and-finance-lease-right-of-use-asset-before-accumulated-depreciation-and-amortization https://stock.noler.com/us/stock/carisma-therapeutics-inc/property-plant-and-equipment-disposals https://stock.noler.com/us/stock/carisma-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/carisma-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/carisma-therapeutics-inc/public-float https://stock.noler.com/us/stock/carisma-therapeutics-inc/receivables-net-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/reclassification-from-aoci-current-period-net-of-tax-attributable-to-parent https://stock.noler.com/us/stock/carisma-therapeutics-inc/reclassifications-of-temporary-to-permanent-equity https://stock.noler.com/us/stock/carisma-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/carisma-therapeutics-inc/reporting-unit-percentage-of-fair-value-in-excess-of-carrying-amount https://stock.noler.com/us/stock/carisma-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/carisma-therapeutics-inc/restricted-cash https://stock.noler.com/us/stock/carisma-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/carisma-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/restricted-cash-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/restricted-cash-noncurrent https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-and-related-cost-expected-cost https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-charges https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-reserve https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-reserve-change https://stock.noler.com/us/stock/carisma-therapeutics-inc/restructuring-reserve-settled-without-cash https://stock.noler.com/us/stock/carisma-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/carisma-therapeutics-inc/revenue https://stock.noler.com/us/stock/carisma-therapeutics-inc/revenue-from-collaborative-arrangement-excluding-revenue-from-contract-with-customer https://stock.noler.com/us/stock/carisma-therapeutics-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/carisma-therapeutics-inc/revenue-recognition-milestone-method-revenue-recognized https://stock.noler.com/us/stock/carisma-therapeutics-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/carisma-therapeutics-inc/revenues https://stock.noler.com/us/stock/carisma-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-finance-lease-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/sale-and-leaseback-transaction-gain-loss-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/sale-leaseback-transaction-accumulated-depreciation https://stock.noler.com/us/stock/carisma-therapeutics-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/carisma-therapeutics-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/carisma-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/carisma-therapeutics-inc/sales-revenue-net https://stock.noler.com/us/stock/carisma-therapeutics-inc/severance-costs https://stock.noler.com/us/stock/carisma-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/carisma-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/carisma-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/carisma-therapeutics-inc/shares-issued-for-acquisitions https://stock.noler.com/us/stock/carisma-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/carisma-therapeutics-inc/shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/carisma-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/carisma-therapeutics-inc/shares-outstanding-2 https://stock.noler.com/us/stock/carisma-therapeutics-inc/short-term-lease-cost https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-award-vesting-rights-percentage https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/carisma-therapeutics-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/carisma-therapeutics-inc/supplemental-unemployment-benefits-severance-benefits https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-tax-contingencies-state-and-local https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/carisma-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/carisma-therapeutics-inc/taxes-payable-current https://stock.noler.com/us/stock/carisma-therapeutics-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/carisma-therapeutics-inc/temporary-equity-carrying-amount-including-portion-attributable-to-noncontrolling-interests https://stock.noler.com/us/stock/carisma-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/carisma-therapeutics-inc/time-deposits-at-or-above-fdic-insurance-limit https://stock.noler.com/us/stock/carisma-therapeutics-inc/total-assets https://stock.noler.com/us/stock/carisma-therapeutics-inc/total-contract-liability https://stock.noler.com/us/stock/carisma-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/carisma-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/carisma-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-basic https://stock.noler.com/us/stock/carisma-therapeutics-inc/undistributed-earnings-loss-allocated-to-participating-securities-diluted https://stock.noler.com/us/stock/carisma-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/carisma-therapeutics-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/carisma-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/carisma-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/carisma-therapeutics-inc/write-off-of-deferred-debt-issuance-cost